Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusive Stroke(TNK-LVO) :a Phase 3, Multicentre, Open-label, Randomised Controlled Trial

NCT06658197 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT06658197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06658197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusive Stroke(TNK-LVO) :a Phase 3, Multicentre, Open-label, Randomised Controlled Trial
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Phase 3
Overall status
Recruiting
Start date
December 25, 2025
Completion date
June 1, 2027
Enrollment
850 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect, stroke, acute, stroke, ischemic, thrombosis, brain